Moreover, developing multiplexed sensors capable of simultaneously detecting multiple biomarkers, such as PCA3 and PSA mRNA, would provide a more comprehensive diagnostic tool, thereby increasing the accuracy and reliability of prostate cancer diagnosis. This evidence concerns the gene KLK3 and prostate carcinoma.